Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network


Omlin A., Amichetti M., Azria D., Cole B. F. , Fourneret P., Poortmans P., ...More

LANCET ONCOLOGY, vol.7, no.8, pp.652-656, 2006 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 7 Issue: 8
  • Publication Date: 2006
  • Doi Number: 10.1016/s1470-2045(06)70765-3
  • Journal Name: LANCET ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.652-656
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Background Outcome data in young women with ductal carcinoma in situ (DCIS) are rare. The benefits of boost radiotherapy in this group are also unknown. We aimed to assess the effect of boost radiotherapy in young patients with DCIS.